Exicure (XCUR) Tax Rate (2022 - 2025)
Exicure (XCUR) reported Tax Rate of 17.95% for Q4 2025, up 2530.0% quarter-over-quarter from 0.74% in Q3 2024.
Exicure (XCUR) Tax Rate (2022 - 2025) Analysis & Trends
Exicure has reported Tax Rate for 3 years, with the latest figure at 17.95% in Q4 2025.
- For the quarter ending Q4 2025, Tax Rate changed N/A year-over-year to 17.95%; the trailing twelve-month figure through Mar 2026 stood at 6.09% (up 622.0% YoY), and the FY2025 full-year result was 11.36%, up 1144.0% from the prior year.
- Tax Rate for Q4 2025 stood at 17.95%, up from 0.74% in the prior quarter.
- The five-year high for Tax Rate was 17.95% in Q4 2025, with the low at 0.74% in Q3 2024.
- Historically, Tax Rate has averaged 6.11% across 3 years, with a median of 1.12% in 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -57.14% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 5.61% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -6.79% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 17.68% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.95% |
| Dec 31, 2025 | 17.95% |
| Sep 30, 2024 | -0.74% |
| Sep 30, 2024 | -0.74% |
| Dec 31, 2022 | 1.12% |
| Dec 31, 2022 | 1.12% |